Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence

International Journal of Infectious Diseases

Volumn 18, Issue 1, 2014, Pages 68-72

  Soundravally, R ^a   Hoti, S L ^b   Patil, Shripad A ^c   Cleetus, C C ^a   Zachariah, Bobby ^a   Kadhiravan, T ^a   Narayanan, P ^a   Kumar, B Agiesh ^d  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b VECTOR CONTROL RESEARCH CENTRE   (India)

^c NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^d SASTRA UNIVERSITY   (India)

Author keywords

DHF; DSS; Lipid peroxides; Malondialdehyde; Proinflammatory cytokine; TNF IFN ratio

Indexed keywords

CYTOKINE; GAMMA INTERFERON; LIPID PEROXIDE; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; COUGHING; CYTOKINE RELEASE; CYTOKINE RESPONSE; DENGUE; DENGUE VIRUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEADACHE; HEMATOCRIT; HEPATOMEGALY; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; PETECHIA; THROMBOCYTE COUNT; VIRUS VIRULENCE; YOUDEN INDEX; YOUNG ADULT;

DHF; DSS; LIPID PEROXIDES; MALONDIALDEHYDE; PROINFLAMMATORY CYTOKINE; TNF-Α/IFN-Γ RATIO;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CYTOKINES; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; INTERFERON-GAMMA; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SEVERE DENGUE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84891555213     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.09.022     Document Type: Article

References (39)

1. Gubler D.J. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998, 11:480-493.
2. Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., et al. The global distribution and burden of dengue. Nature 2013, 10.1038/nature12060.
3. Rigau-Perez J.G., Clark G.G., Gubler D.J., Reiter P., Sanders E.J., Vorndam A.V. Dengue and dengue haemorrhagic fever. Lancet 1998, 352:971-977.
4. Seet R.C., Lee C.Y., Lim E.C., Quek A.M., Yeo L.L., Huang S.H., Halliwell B., et al. Oxidative damage in dengue fever. Free Radic Biol Med 2009, 47:375-380.
5. Palamara A.T., Perno C.F., Ciriolo M.R., Dini L., Balestra E., D'Agostinin C., Di Francesco P., Favalli C., Rotilio G., Garaci E., et al. Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication. Antiviral Res 1995, 27:237-253.
6. Droge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H.P., Roth S., Gmunder H., et al. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J 1994, 8:1131-1138.
7. Gil L., Martinez G., Tapanes R., Castro O., Gonzalez D., Bernardo L., et al. Oxidative stress in adult dengue patients. Am J Trop Med Hyg 2004, 71:652-657.
8. Soundravally R., Hoti S.L., Bobby Z., Selvaraj N. Desialylation of plasma proteins in severe dengue infection: possible role of oxidative stress. Am J Trop Med Hyg 2008, 79:372-377.
9. Soundravally R., Sankar P., Bobby Z., Hoti S.L. Oxidative stress in severe dengue viral infection: association of thrombocytopenia with lipid peroxidation. Platelets 2008, 19:447-454.
10. Chaturvedi U.C., Elbishbishi E.A., Agarwal R. Sequential production of cytokines by dengue virus-infected human peripheral blood leukocytes cultures. J Med Virol 1999, 59:335-340.
11. Anon S., Sharone G. Markers of dengue disease severity. Curr Top Microbiol Immunol 2010, 338:67-82.
12. Chaturvedi U.C., Agarwal R., Elbishbishi E.A., Mustafa A.S. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 2000, 28:183-188.
13. Iyngkaran N., Yadav M., Sinniah M. Augmented inflammatory cytokines in primary dengue infection progressing to shock. Singapore Med J 1995, 36:218-221.
14. Hober D., Poli L., Roblin B., Gestas P., Chunque E., Granic G., et al. Serum levels of tumor necrosis factor-alpha (TNF alpha), interleukin-6 (IL-6), and interleukin-1beta (IL-1beta) in dengue-infected patients. Am J Trop Med Hyg 1993, 48:324-331.
15. Bethell D.B., Flobbe K., Cao X.T., Day N.P., Pham T.P., Buurman W.A., et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis 1993, 177:778-782.
16. Yadav M., Kamath K.R., Iyngkaran N., Sinniah M. Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders. FEMS Microbiol Immunol 1991, 4:45-49.
17. Azeredo E.L., Zagne S.M., Santiago M.A., Gouvea A.S., Santana A.A., Neves-Souza P.C., et al. Characterization of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 2001, 204:494-507.
18. Braga E.L., Moura P., Pinto L.M., Ignacio S.R.N, Oliveira M.J.C., Cordeiro M.T., et al. Detection of circulant tumor necrosis factor alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. Mem Inst Oswaldo Cruz 2001, 96:229-232.
19. Levy A., Valero N., Espina L.M., Anez G., Arias J., Mosquera J. Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue. Trans R Soc Trop Med Hyg 2010, 104:16-23.
20. Nielsen F., Mikkelsen B.B., Nielsen J.B., Andersen H.R., Granjean P. Plasma malondialdehye as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997, 43:1209-1214.
21. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention, and control. Geneva: WHO; 1997. Available at: http://whqlibdoc.who.int/publications/1997/9241545003_eng.pdf.
22. Lanciotti R.S., Calisher C.H., Gubler D.J., Chang G.J., Vorndam V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase polymerase chain reaction. J Clin Microbiol 1992, 30:545-551.
23. Satoh K. Serum lipid peroxide in CVD determined by new colorimetric method. Clin Chem Acta 1978, 90:37-43.
24. Youden W.S. Index for rating diagnostic tests. Cancer 1950, 3:32-35.
25. Restrepo B.N., Isaza D.M., Salazar C.L., Ramírez R., Ospina M., Alvarez L.G. Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gamma in infants with and without dengue. Rev Soc Bras Med Trop 2008, 41:6-10.
26. Bozza F.A., Cruz O.G., Zagne S.M., Azeredo E.L., Nogueira R.M., Assis E.F., et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 2008, 8:86. 10.1186/1471-2334-8-86.
27. Chakravarti A., Kumaria R. Circulating levels of tumor necrosis factor-alfa and interferon gamma in patients with dengue and dengue haemorrhagic fever during an outbreak. Indian J Med Res 2006, 123:25-30.
28. Libraty D.H., Endy T.P., Houng H.S., Green S., Kalayanarooj S., Suntayakorn S., et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002, 185:1213-1221.
29. Mabalirajan U., Kadhiravan T., Sharma S.K., Banga A., Ghosh B. Th(2) immune response in patients with dengue during defervescence: preliminary evidence. Am J Trop Med Hyg 2005, 72:783-785.
30. Priyadarshini D., Gadia R.R., Tripathy A., Gurukumar K.R., Bhagat A., Patwardhan S., et al. Clinical findings and pro-inflammatory cytokines in dengue patients in western India: a facility-based study. PLoS One 2010, 5:e8709. 10.1371/journal.pone.0008709.
31. Selby P., Hobbs S., Viner C., Jackson E., Jones A., Newell D., et al. Tumour necrosis factor in man: clinical and biological observations. Br J Cancer 1987, 56:803-808.
32. Tracey K.J., Fong Y., Hesse D.G., Manoque K.R., Lee A.T., Kuo G.C., et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987, 330:662-664.
33. Atrasheuskaya A., Petzelbauer P., Fredeking T.M., Ignatyev G. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol Med Microbiol 2003, 35:33-42.
34. Yen Y.T., Chen H.C., Lin Y.D., Shieh C.C., Wu-Hsieh B.A. Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development. J Virol 2008, 82:12312-12324.
35. Restrepo B.N., Ramirez R.E., Arboleda M., Alvarez G., Ospina M., Diaz F.J. Serum levels of cytokines in two ethnic groups with dengue virus infection. Am J Trop Med Hyg 2008, 179:673-677.
36. Rathakrishnan A., Wang S.M., Hu Y., Khan A.M., Ponnampalavanar S., See Lum L.C., et al. Cytokine expression profile of dengue patients at different phases of illness. PLoS One 2012, 7:e52215. 10.1371/journal.pone.0052215.
37. Chaturvedi U.C., Nagar R. Dengue and dengue haemorrhagic fever: Indian perspective. J Biosci 2008, 33:429-441.
38. Soundravally R., Sankar P., Hoti S.L., Selvaraj N., Bobby Z., Sridhar M.G. Oxidative stress induced changes in plasma protein can be a predictor of imminent severe dengue infection. Acta Trop 2008, 106:156-161.
39. Wang J., Chen Y., Gao N., Wang Y., Tian Y., Wu J., et al. Inhibitory effect of glutathione on oxidative liver injury induced by dengue virus serotype 2 infections in mice. PLoS One 2013, 8:e55407. 10.1371/journal.pone.0055407.